UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)		Common Stock [Member]	Stock Subscription Receivable [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2023		$ 25,000	$ (25,000)	$ (3,680)	$ (3,680)
Beginning balance, shares at Dec. 31, 2023		1,725,000
Capital contribution paid			25,000		25,000
Net loss				(25,346)	(25,346)
Ending balance, value at Mar. 31, 2024	[1]	$ 25,000	0	(29,026)	(4,026)
Ending balance, shares at Mar. 31, 2024		1,725,000
Beginning balance, value at Dec. 31, 2023		$ 25,000	(25,000)	(3,680)	(3,680)
Beginning balance, shares at Dec. 31, 2023		1,725,000
Allocation of offering costs to ordinary shares subject to possible redemption					2,661,858
Net loss					(17,788)
Ending balance, value at Sep. 30, 2024	[1]	$ 0	0	(726,007)	(726,007)
Ending balance, shares at Sep. 30, 2024		1,975,000
Beginning balance, value at Mar. 31, 2024	[1]	$ 25,000	0	(29,026)	(4,026)
Beginning balance, shares at Mar. 31, 2024		1,725,000
Net loss				(16,164)	(16,164)
Ending balance, value at Jun. 30, 2024	[1]	$ 25,000	0	(45,190)	(20,190)
Ending balance, shares at Jun. 30, 2024		1,725,000
Sale of units in initial public offering, net of offering costs		$ 57,159,797			57,159,797
Sale of units in initial public offering, net of offering costs, shares		6,000,000
Sale of units to the founder in private placement		$ 2,500,000			2,500,000
Sale of units to the founder in private placement, shares		250,000
Initial classification of ordinary shares subject to possible redemption		$ (56,232,427)			(56,232,427)
Initial classification of ordinary shares subject to possible redemption, shares		(6,000,000)
Allocation of offering costs to ordinary shares subject to possible redemption		$ 2,661,858			2,661,858
Subsequent remeasurement of ordinary shares subject to possible redemption				(89,336)	(89,336)
Net loss				23,722	23,722
Accretion of carrying value to redemption value		(6,114,228)		(615,203)	(6,729,431)
Ending balance, value at Sep. 30, 2024	[1]	$ 0	0	(726,007)	(726,007)
Ending balance, shares at Sep. 30, 2024		1,975,000
Beginning balance, value at Dec. 31, 2024		$ 0	0	(905,321)	(905,321)
Beginning balance, shares at Dec. 31, 2024		1,750,000
Subsequent remeasurement of ordinary shares subject to possible redemption				(639,703)	(639,703)
Net loss				547,299	547,299
Ending balance, value at Mar. 31, 2025		$ 0	0	(997,725)	(997,725)
Ending balance, shares at Mar. 31, 2025		1,750,000
Beginning balance, value at Dec. 31, 2024		$ 0	0	(905,321)	(905,321)
Beginning balance, shares at Dec. 31, 2024		1,750,000
Allocation of offering costs to ordinary shares subject to possible redemption					0
Net loss					1,041,201
Ending balance, value at Sep. 30, 2025		$ 0	0	(1,799,020)	(1,799,020)
Ending balance, shares at Sep. 30, 2025		1,750,000
Beginning balance, value at Mar. 31, 2025		$ 0	0	(997,725)	(997,725)
Beginning balance, shares at Mar. 31, 2025		1,750,000
Subsequent remeasurement of ordinary shares subject to possible redemption				(643,564)	(643,564)
Net loss				(24,750)	(24,750)
Ending balance, value at Jun. 30, 2025		$ 0	0	(1,666,039)	(1,666,039)
Ending balance, shares at Jun. 30, 2025		1,750,000
Subsequent remeasurement of ordinary shares subject to possible redemption				(651,633)	(651,633)
Net loss				518,652	518,652
Ending balance, value at Sep. 30, 2025		$ 0	$ 0	$ (1,799,020)	$ (1,799,020)
Ending balance, shares at Sep. 30, 2025		1,750,000

[1] Excludes up to an aggregate of 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. In November 2024, the underwriter did not exercise their 45-day option to purchase 900,000 Units, therefore 225,000 founder shares are forfeited.